Description
Librela for dogs.
Uses
Indicated for the alleviation of pain associated with osteoarthritis in dogs.
Dosage and administration
For subcutaneous use.
Dosage and treatment schedule
The recommended dose is 0.5-1.0 mg/kg bodyweight, once a month.
For dogs weighing <5.0 kg aseptically withdraw 0.1 ml/kg from a single 5 mg/ml vial and administer subcutaneously.
For dogs between 5 and 60 kg administer the entire content of the vial (1 ml) according to the table below:
|
LIBRELA strength (mg) to be administered
|
|||||
|
Bodyweight (kg) of dog
|
5
|
10
|
15
|
20
|
30
|
|
5.0 – 10.0
|
1 vial
|
||||
|
10.1 – 20.0
|
1 vial
|
||||
|
20.1 – 30.0
|
1 vial
|
||||
|
30.1 – 40.0
|
1 vial
|
||||
|
40.1 – 60.0
|
1 vial
|
||||
|
60.1 – 80.0
|
2 vials
|
||||
|
80.1 – 100.0
|
1 vial
|
1 vial
|
|||
|
100.1 – 120.0
|
2 vials
|
||||
For dogs above 60 kg, the contents of more than one vial are required to administer a single dose. In those cases, withdraw the content from each required vial into the same syringe and administer as a single subcutaneous injection (2 ml).
